Next Article in Journal
Fermented Beverages Revisited: From Terroir to Customized Functional Products
Previous Article in Journal
Performance of Recombinant Komagataella phaffii in Plant-Based Meat Flavor Compound-Leghemoglobin (LegH) Production through Fed-Batch Fermentations
Previous Article in Special Issue
High Production of Nattokinase via Fed-Batch Fermentation of the γ-PGA-Deficient Strain of Bacillus licheniformis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Fermentation
Volume 10
Issue 1
10.3390/fermentation10010056
fermentation-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Engineering an Artificial Pathway to Improve the Bioconversion of Lysine into Chiral Amino Alcohol 2-Hydroxycadaverine Using a Semi-Rational Design

by
Jie Cheng
1,*,†,
Shujian Xiao
1,†,
Qing Luo
2,
Bangxu Wang
1,
Rumei Zeng
1,
Liming Zhao
3 and
Jiamin Zhang
1
1
College of Food and Bioengineering, Chengdu University, Chengdu 610106, China
2
Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China
3
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Fermentation 2024, 10(1), 56; https://doi.org/10.3390/fermentation10010056
Submission received: 13 November 2023 / Revised: 28 December 2023 / Accepted: 12 January 2024 / Published: 13 January 2024
(This article belongs to the Special Issue Applications of Enzymes in Biosynthesis)
Browse Figures
Review Reports Versions Notes

Abstract

:
Amino alcohols are important compounds that are widely used in the polymer and pharmaceutical industry, particularly when used as chiral scaffolds in organic synthesis. The hydroxylation of polyamide polymers may allow crosslinking between molecular chains through the esterification reactions of hydroxyl and carboxyl groups. Therefore, this may alter the functional properties of polyamide polymers. 2-hydroxycadaverine (2HyC), as a new type of chiral amino alcohol, has potential applications in the pharmaceutical, chemical, and polymer industries. Currently, 2HyC production has only been realized via pure enzyme catalysis or two-stage whole-cell biocatalysis, which faces great challenges for scale-up production. However, the use of a cell factory is very promising for the production of 2HyC in industrial applications. Here, we designed and constructed a promising artificial pathway in Escherichia coli for producing 2HyC from biomass-derived lysine. This biosynthesis route expands the lysine catabolism pathway and employs two enzymes to sequentially convert lysine into 2HyC. However, the catalytic activity of wild-type pyridoxal phosphate-dependent decarboxylase from Chitinophage pinensis (DCCp) toward 3-hydroxylysine is lower, resulting in the lower production of 2HyC. Thus, the higher catalytic activity of DCCp is desired for low-cost and expanded industrial applications of 2HyC. To improve the catalytic activity of DCCp, a mutant library of DCCp was first built using a semi-rational design. The Kcat/Km of mutant DCCp (R53D/V94I) increased by 63%. A titer of 359 mg/L 2HyC was produced in shake flasks, with a 2HyC titer increase of 54% compared to control strain ML101. The results show that the production of 2HyC was effectively increased through a semi-rational design strategy. These findings lay the foundation for the development and utilization of renewable resources to produce 2HyC in microorganisms via an efficient, green, and sustainable biosynthetic strategy for further industrial application.

1. Introduction

The core of synthetic biology is to reshape natural biological systems to produce natural or non-natural chemicals [1,2]. Recently many important high-value chemicals have been produced in microorganisms via synthetic biology, such as L-pipecolic acid [3], rosmarinic acid [4], pigments [5], caffeic acid [6], 5-hydroxyectoine [7], quercetin [8], 2-keto-L-gulonic acid [9], ergothioneine [10], monoterpene [11], ectoine [12], and glutarate [13]. These natural or non-natural chemicals and their derivatives are widely used in diverse fields [14].
Enzyme-mediated C-H hydroxylation is an attractive strategy for diversifying amino acids and their derivatives [15]. C-H hydroxylation is a promising strategy to synthesize hydroxy amino acids (HAAs), which are widely used in the chemical, feed, and medicinal industries [16]. For example, 5-hydroxytryptophan is the functional precursor for the synthesis of serotonin, exhibiting important pharmaceutical activity [17]. Moreover, N-hydroxy-pipecolic acid is an important systemically acquired resistance signal molecule [18]. Trans-4-hydroxy-L-pipecolic acid is a direct intermediate for the synthesis of bioactive cyclopeptide MBJ-0110 and bromopyrrole alkaloid damipipecolin [19].
The functionalization of amino acids and their derivatives has facilitated the production of compounds with multiple functions, thereby expanding their application fields and scope [20]. Hydroxylysines are a series of hydroxylated derivatives of lysine comprising 3-hydroxylysine, 4-hydroxylysine, 5-hydroxylysine, and diohydroxylysines, which are widely used as building blocks in the chemical, feed, and pharmaceutical industries [21]. Hydroxylysines are widely used as precursors in the pharmaceutical industry, such as palinavir [22], tambromycin [23], balanol, cepafungin I, and glidobactin A [24]. Hydroxylysines are also important monomers of polyamides, as their decarboxylation produces hydroxylated terminal diamines, which can be used to produce new bio-based polyamides [25].
Amino alcohols (AAs) are important adjuvants and ligands in organic synthesis and biology, with the dual chemical properties of amine and alcohol [26]. As shown in Figure 1B, bifunctional compounds of chiral AAs are widely applied in many important fields of medicine, fine chemicals, materials, and asymmetric catalysis [26]. AAs are the precursor of polypeptide drugs such as Octreotide, Ziconotide, and Alamethicin F-30, nucleotide drugs such as Glycopeptidolipid, quinolone drugs such as Levofloxacin and Pazufloxacin, and radioactive drugs such as Lopamidol [27]. In addition, AAs have low toxicity and low viscosity, inhibit corrosion, absorb carbon dioxide, and cure at room temperature. Zhang et al. reported the reductive amination of transaminase to synthesize 2-amino-2-phenylethanol, resulting in 68.6 g/L/d of volumetric productivity of 2-amnio-2-phenylethanol [28]. Because biocatalysis has the advantage of high stereoselectivity, biocatalysis can provide a superior route for the synthesis of chiral AAs [29]. In particular, Steinreiber et al. reported the synthesis of chiral AA 2-amino-1-phenylethanol using the double enzyme cascade reaction of L-threonine aldolase and L-tyrosine decarboxylase [30].
2-hydroxycadaverine (2HyC) is a novel chiral AA with potential applications in medicine [31], chemistry, and materials [32]. 2HyC can be produced from L-lysine via hydroxylation and subsequent decarboxylation [21]. First, lysine was hydroxylated to generate 3-hydroxylysine by lysine hydroxylase. Subsequently, 3-hydroxylysine was decarboxylated by decarboxylase to form 2HyC [21,27]. Baud et al. reported the direct synthetic route of 2HyC from L-lysine via enzymatic reactions using purified lysine hydroxylase KDO1 and purified lysine decarboxylase [21]. However, pure enzyme catalysts are limited in their application due to their cumbersome purification steps and high cost [33]. Li et al. first established a two-stage biocatalytic approach for the direct production of 2HyC from L-lysine via whole-cell biotransformation [27].
In this work, an artificial route for the production of AA 2-hydroxycadaverine with lysine hydroxylase from Kineococcus radiotolerans (KDOKr) and pyridoxal phosphate-dependent decarboxylase from Chitinophage pinensis (DCCp) overexpression was illustrated in Figure 1A. Firstly, lysine was hydroxylated to generate 3-hydroxylysine using KDOKr. Subsequently, 3-hydroxylysine was decarboxylated by DCCp to form AA 2HyC. In the present study, a semi-rational design strategy was carried out to engineer DCCp. DCCp was generated using AlphaFold 2 [34], and molecular docking was performed using the AutoDock 4.2.6 package (The Scripps Research Institute, San Diego, CA, USA). A53, N54, V94, K95, and A97 were selected for site-directed saturation mutagenesis. With this method, a mutant DCCp (R53D/V94I) was screened out with a 63% increase in catalytic efficiency relative to the wild type. The titer of 2HyC reached 359 mg/L in 24 h. Moreover, mutants of DCCp with higher catalytic efficiency toward 3-hydroxylysine were obtained using the semi-rational design, which provides a theoretical foundation and preliminary information for the production of 2HyC to meet industrial requirements.

2. Materials and Methods

2.1. Strains and Plasmids

The bacterial strains and plasmids used in this study are shown in Table 1. E. coli BL21(DE3) was used as the host strain to produce 2-hydroxycadaverine. Strain BL21(DE3) with the cadA gene knocked out was conducted in our previous studies [3]. The nucleotide sequence of the lysine hydroxylase (EC 1.14.11.4) gene from Kineococcus radiotolerans (KDOKr) is available in GenBank with the accession number ABS05421.1. The protein sequence of pyridoxal phosphate-dependent decarboxylase (EC 4.1.1) from Chitinophaga pinensis (DCCp) is available in GenBank with the accession number WP_012790490.1. Codon-optimized KDOKr (Seen in Supplementary Data S1) was chemically synthesized and inserted into pET22b to form plasmid pET22b-KDOKr with NdeI and BamHI restriction sites. Codon-optimized DCCp (as seen in Supplementary Data S2) was chemically synthesized and inserted into pET22b and pET22b-KDOKr to form plasmid pET22b-DCCp and pET22b-KDOKr-DCCp with SalI and XhoI restriction sites, respectively. The sequences of all vector constructs were verified using Sanger sequencing (Sangon Biotech Co., Ltd., Shanghai, China).

2.2. Culture Medium and Conditions

E. coli ML10, ML101, or ML11 strains were cultured in 100 mL flasks containing 10 mL of the Luria–Bertani (LB) medium supplemented with 100 μg/mL of Amp for 12 h at 37 °C and 220 rpm. Then, 20 μL of the culture was transferred into a 100 mL flask containing 20 mL of the medium (comprising 10 g/L of tryptone, 5 g/L of yeast extract, 0.1 mM of pyridoxal phosphate, 0.5 g/L of K2PO4·3H2O, 3 g/L of KH2PO4, 0.75 g/L of FeSO4·7H2O, 15 g/L of glucose, 20 of mM α-ketoglutarate and 100 μg/mL of Amp) at 37 °C and 220 rpm. After the OD600 reached 0.6, 0.5 mM IPTG and 4 g/L lysine was added and continued in the culture at 30 °C. L-lysine, 3-hydroxylysine, and 2-hydroxycaverine were measured using HPLC.
The production of 2HyC in recombinant E. coli ML101 and ML102 was conducted in 250 mL flasks. Strains ML101 and ML102 from the glycerol stock were streaked onto LB agar plates supplemented with 100 μg/mL Amp and grown overnight in an incubator at 37 °C. Three colonies were selected from an agar plate and grown in 5 mL of LB medium supplemented with 100 μg/mL Amp in an orbital shaker operated overnight at 220 rpm and 37 °C. The culture was adopted as the seed inoculum to initiate fermentation in triplicate. The fermentation medium was inoculated with the seed broth at 1% dilution and grown in 40 mL of the LB medium (comprising 10 g/L of tryptone, 5 g/L of yeast extract, 0.1 mM of pyridoxal phosphate, 0.5 g/L of K2PO4·3H2O, 3 g/L of KH2PO4, 0.75 g/L of FeSO4·7H2O, 15 g/L of glucose, 20 mM of α-ketoglutarate and 100 μg/mL of Amp). The initial pH was adjusted to 7.0. After the OD600 reached 0.6, 4 g/L of L-lysine was added to the fermentation medium as a substrate at this time, and IPTG was added to a final concentration of 0.5 mM to induce the protein expression. The flasks were placed in an orbital shaker operated at 220 RPM and 30 °C. Experiments were performed in triplicate, and samples were taken at 12 and 24 h for 2HyC analysis.

2.3. Protein Expression and Purification

For the protein expression, ML03 harboring pET22b-DCCp was screened on selective LB agar plates supplemented with 100 μg/mL of Amp. Positive clones were inoculated in 2 mL of the fresh LB medium at 37 °C and 220 rpm for 12 h. A total of 2 mL of seed cultures was transferred into 200 mL of LB containing 100 μg/mL of Amp. When the OD600 reached 0.6, a final concentration of 0.5 mM IPTG was employed and incubated for a low-temperature induction culture at 20 °C for 16 h. The cells were collected via centrifugation at 10,000 RPM for 5 min at 4 °C. The cells were resuspended and washed twice with a potassium phosphate buffer (KPB, 50 mM, pH 8.0), and 2 mM of tris (2-carboxyethyl) phosphine (TCEP) was added in an ice bath. The cells were disrupted via ultrasonication for 15 min in an ice bath. The enzymes were purified using an AKTA Purifier 10 and a Ni-NTA column (GE Healthcare, Chicago, IL, USA). The purified enzymes were desalted and exchanged into a storage buffer (50 mM of KPB, 1.0 mM of MgSO4, 2 mM of TCEP, 10% glycerol, and pH 8.0) and stored at −80 °C [36]. The UV absorbance at 280 nm was used to measure the protein concentration using SpectraMax M2e (Molecular Devices, San Jose, CA, USA) [37,38].

2.4. Homology Modeling and Molecular Docking

The theoretical structures of native KDOKr and DCCp were generated using AlphaFold2 [34]. The initial structure was processed with AutoDockTools 1.5.6, preserving the original charge of the protein and generating a pdbqt file for docking. The ligands L-lysine and 3-hydroxylysine were docked into the pocket of KDOKr and DCCp using the AutoDock 4.2.6 package, respectively, where the lowest energy conformation in the largest cluster was considered to be an approximately natural complex model [39]. The energy optimization used the Amber14 force field.

2.5. Site-Directed Saturation Mutagenesis

E. coli was used as the chassis cell to screen DCCp mutants via an activity-linked screening method. For the construction of DCCp mutants, a semi-rational design strategy based on structural orientation was used. Here, the structure was modeled by AlphaFold2 and docked with 3-hydroxylysine. First, saturation mutagenesis was conducted at potential improvement sites in DCCp (accession number: WP_012790490.1) through whole plasmid PCR using degenerate primers. Degenerate primers containing NNK (the forward primer) were used for saturation mutagenesis at the corresponding mutation sites, where N represents the bases T, A, C, or G, and K represents T or G. To eliminate the primary template, the PCR products were digested by DpnI at 37 °C for 1 h and then directly transformed into E. coli BL21(DE3) competent cells to produce the variants. All the positive mutations were transformed into E. coli BL21(DE3) for the expression of the DCCp protein. The DCCp activity and protein concentration were measured to calculate the increase in DCCp activity for screened mutants. All experiments were carried out in triplicate.

2.6. Enzyme Assay

The determination of DCCp activity was carried out according to the method described by Prell et al. [40]. In total, 1.5 mL of the reaction mix contained 50 mM of the HEPES buffer (pH 7.5), 1 mM of PLP, 1 mM of DTT, and 10 mM of 3-hydroxylysine [21,40]. The reaction was started by the addition of 1 mg/mL of the protein. The reaction was conducted at 30 °C and stopped by adding 10 μL of 10 M HCl. All experiments were carried out in triplicate.

2.7. Analytical Methods

L-lysine, 3-hydroxylysine, and 2-hydroxycadaverine were analyzed and quantitated using HPLC (Agilent Technologies 1200 series, Hewlett-Packard, Palo Alto, CA, USA). The sample was derived with phenyl isothiocyanate (PITC) for the detection of lysine [18]. Samples were analyzed using HPLC with a C18 column (4.6 × 250 mm) and a Chirex®3126 (D)-penicillamine LC column (4.6 × 250 mm, Phenomenex, Torrance, CA, USA) as described by Cheng et al. [3]. The samples were centrifuged and filtered using a 0.22 μm membrane.

3. Results and Discussion

3.1. Construction of a Heterogeneous Pathway for 2HyC Production in Engineered E. coli ML101

To engineer the 2HyC pathway, pET22b-KDOKr-DCCp was constructed for the synthesis of 2HyC (Figure 1A). The designed heterogeneous pathway of 2HyC consists of two steps. The first step was to convert lysine into 3-hydroxylysine mediated by KDOKr. The second step was to convert 3-hydroxylysine into 2HyC mediated by DCCp. In this study, we tried to introduce a decarboxylase from Chitinophage pinensis (DCCp) in combination with KDOKr for 2HyC production from lysine. The sequence of KDOKr and DCCp was optimized according to the codon preference of E. coli. Firstly, plasmid pET22b-KDOKr-DCCp was constructed. Then, the plasmid pET22b-KDOKr-DCCp was transformed into E. coli ML03 and strain ML101 was obtained. As shown in Table 2, we investigated the production of 3-hydroxylysine and 2HyC from lysine in strain ML101. When 2 g/L of L-lysine was fed to recombinant E. coli ML101, 106.18 mg/L of 2HyC was obtained after 12 h (Table 2). A titer of 195.37 mg/L of 2HyC was produced with 4 g/L of lysine added after 12 h. Our data clearly demonstrate that the heterogeneous pathway of 2HyC in E. coli is feasible. Although the 2HyC synthesis pathway we have established can synthesize 2HyC, the titer is relatively low. We hypothesized that the low enzymatic activity of DCCp was the main limitation [21].

3.2. Molecular Docking Studies

To gain a better insight into the interaction between KDOKr and L-lysine on the molecular level, a molecular docking study was performed. As shown in Figure 2A, after 108 accurate runs, the mainly 12 binding sites on the KDOKr were observed with the binding energy of −4.95 kcal/mol for the strongest binding site. According to the principle of minimum energy, the conformation with the lowest binding energy was selected as the final result of molecular docking. As shown in Figure 2B, L-lysine was mainly bound to KDOKr in the hydrophobic cavity, forming a hydrophobic interaction with the surrounding amino acids under the molecular docking binding energy of −4.95 kcal/mol.
After that, the analysis of the binding mode was performed to specifically clarify the binding mechanism. As shown in Figure 2C,D, the docking results of KDOKr and L-lysine showed that L-lysine formed four hydrogen bonds with the side chains E123, G124, S144, and R305. In addition, the binding of KDOKr with L-lysine could be attributed to a hydrophobic interaction because strong hydrophobic interactions of L-lysine with N93, M132, Q143, and Q145 were formed. The molecular docking results showed that L-lysine could bind to the hydrophobic cavity of KDOKr due to the formation of hydrogen bonds and hydrophobic interactions with surrounding amino acid residues.
In order to analyze the interaction between 3-hydroxylysine and DCCp, we analyzed the interaction between 3-hydroxylysine and DCCp at the best binding site, as shown in Figure 3. As seen in Figure 3A,B, it can be observed that 3-hydroxylysine can stably bind to the active cavity formed by the interweaving of several helical structures in DCCp. Furthermore, the analysis of the interaction between 3-hydroxylysine and DCCp shows that there are a large number of hydrogen bond donors and receptor groups in 3-hydroxylysine, which forms a large number of hydrogen bonds with amino acids around the pocket to promote the stable binding of 3-hydroxylysine to DCCp. As seen in Figure 3C,D, 3-hydroxylysine forms hydrogen bonds with five amino acid residues around the DCCp pocket. The docking results of DCCp and 3-hydroxylysine showed that 3-hydroxylysine formed five hydrogen bonds with the side chain A53, N54, V94, K95, and A97. In addition, a strong hydrophobic interaction of 3-hydroxylysine with K95 was formed, further enhancing the affinity between 3-hydroxylysine and DCCp.

3.3. Iterative Saturation Mutagenesis of DCCp to Improve the Catalytic Activity toward 3-Hydroxylysine

Although we constructed an artificial biosynthetic route of chiral amino alcohol 2HyC when we introduced KDOKr and DCCp into E. coli ML03 (ML101) and cultivated ML101 in a flask, the accumulation of 2HyC in the culture was very low. In order to promote the production of 2HyC, we hoped to improve the catalytic capability of DCCp. To enhance the production of 2HyC, a mutant library of DCCp was established using a semi-rational design to improve the catalytic activity of DCCp. The semi-rational design of enzymes based on the 3D structure and molecular docking has been proven to reduce the workload of constructing and screening mutation libraries [41,42]. Therefore, sites R53, N54, V94, K95, and A97 of DCCp were selected for subsequent iterative saturation mutagenesis.
The enzyme assays showed that the saturation mutants of N54, K95, and A97 could not enhance the specific activity. Most of the substitutions at R53 and V94 reduced the specific activity, and two mutants had no significant effect on the specific activity. The specific activity of mutations R53D, R53E, V94A, and V94I was significantly higher than wild type (Table 3). DCCp exhibited low activity toward 3-hydroxylysine, whereas DCCp mutations (R53D/V94I and R53E/V94I) displayed enhanced activities in Table 3. The DCCp variant R53D/V94I showed the greatest activity in Table 3. Wild-type DCCp showed a Km value of 20.72 mM, a Kcat value of 1.86 s−1, and a Kcat/Km value of 0.0898 mM−1s−1 when 3-hydroxylysine was used as the substrate. Mutation DCCp (R53D) displays a Km value of 18.05 mM, a Kcat value of 2.08 s−1, and a Kcat/Km value of 0.1152 mM−1s−1 with 3-hydroxylysine used as the substrate shown in Table 3. The mutations DCCp (R53E), DCCp (R53E), DCCp (V94A), DCCp (V94I), DCCp (R53E/V94I), and DCCp (R53D/V94I) showed a Km value of 19.21, 18.48, 17.96, 17.12, 16.33 mM, a Kcat value of 2.13, 2.24, 2.19, 2.25, 2.39 s−1, and a Kcat/Km value of 0.1109, 0.1212, 0.1097, 0.1314, 0.1466 mM−1s−1, respectively, when 3-hydroxylysine was used as the substrate shown in Table 3. The Kcat/Km of the mutant DCCp (R53D/V94I) increased by 0.63-fold compared to wild-type DCCp. These findings promote an understanding of the structure–function relationship of DCCp and increase its catalytic efficiency for further industrial application. The enzyme activity assay showed that the DCCp enzyme has no activity against lysine.
Currently, there is no study on enhancing 2HyC production using enzyme engineering strategies or semi-rational design strategies. Previous studies usually use metabolic engineering to enhance 2HyC production, including the heterologous expression of key genes and using a purified enzyme catalytic system [21]. Baud et al. reported a direct synthetic route of 2HyC from L-lysine via enzymatic reactions using purified lysine hydroxylase KDO1 and purified lysine decarboxylase [21]. However, pure enzyme catalysts are limited in their application due to their cumbersome purification steps and high cost [33]. Recently, a two-stage biocatalytic approach for the direct production of 2HyC from L-lysine via whole-cell biotransformation was first established by Li et al. [27]. In the decarboxylation step, decarboxylase CadA can decarboxylate not only 3-hydroxylysine but also lysine [27]. Therefore, 2HyC can only be synthesized using a two-stage biocatalytic approach in this research [27]. The enzyme engineering strategy can include the iterative saturation mutagenesis of the key sites to improve the activity of the enzyme. In the present study, DCCp (R53D/V94I) produced the highest titer of 2HyC. V94 is located in the substrate pocket, so V94 may change the shape of the hydrophobic cavity of the substrate pocket.

3.4. Metabolic Engineering of E. coli ML102 for 2HyC Production

2HyC is accessible as the product of the direct hydroxylation and decarboxylation of lysine; 2HyC, on the other hand, is a non-naturally occurring compound; thus, it is not described in organisms naturally. Based on the enzyme catalytic properties measured in vitro, we sought to build this artificial metabolic route in E. coli to produce 2HyC by expressing KDOKr and DCCp enzymes, as seen in Figure 1A. In order to improve the catalytic capability of DCCp, a mutant library of DCCp was established through a semi-rational design strategy. The greatest activity of the DCCp variant R53D/V94I was obtained. To further evaluate the potential fermentation performance of the DCCp variant R53D/V94I, fermentation evaluation was conducted on strain ML102. After 24 h of aerobic cultivation, there was no accumulation of 2HyC in the control strain ML03. The OD600 reached 4.05 after 8 h and 5.86 after 12 h. On the other hand, the engineered strain ML101 and ML102 produced 2HyC with a peak concentration of 195.37 mg/L and 304.27 mg/L at 12 h, as shown in Figure 4, respectively. The successful assembly of this artificial pathway in E. coli validates the feasibility of producing L-lysine-derived 2HyC. In this study, our engineered E. coli strain ML102 could use lysine as a substrate to produce 2HyC with a titer of 359 mg/L after 24 h, with a 2HyC titer increase of 54% compared to the control strain ML101, as seen in Figure 4.

4. Conclusions

Chiral AAs have tremendous utility in various industries, including adjuvants and ligands. In conclusion, we described a biotransformation system utilizing KDOKr and DCCp to convert L-lysine to 2HyC in E. coli. An engineered E. coli strain, ML102, with KDOKr and DCCp (R53D/V94I) overexpression, can produce 359 mg/L of 2HyC from L-lysine in a 250 mL flask. This work provides a sustainable route for industrial 2HyC production from renewable feedstocks using metabolic engineering. This study started with the structure prediction of DCCp. Subsequently, the double mutant DCCp (R53D/V94I) was obtained via iterative saturation uutagenesis. In this study, DCCp mutants with catalytic activity enhanced up to 0.63-fold were obtained from a smart mutant library using a semi-rational design. These findings promoted an understanding of the structure–function relationship of DCCp and improved its catalytic efficiency for industrial application. This study demonstrates the production of 2HyC in E. coli, which is an important step in developing E. coli into an industrial strain for producing 2HyC. Future engineering efforts can utilize directed evolution and rational design strategies to produce a higher titer of 2HyC in E. coli, although additional enzyme and strain optimization may be required.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/fermentation10010056/s1, Table S1: The OD600 value at specific times of strains ML101 and ML102; Data S1: The codon-optimized nucleotide sequence of lysine hydroxylase from Kineococcus radiotolerans (KDOKr); Data S2: The codon-optimized nucleotide sequence of pyridoxal phosphate-dependent decarboxylase from Chitinophaga pinensis (DCCp).

Author Contributions

Writing—original draft preparation, J.C. and S.X.; writing—review and editing, Q.L., B.W., R.Z., L.Z. and J.Z.; visualization, J.C.; supervision, J.C.; project administration, J.C. and L.Z.; funding acquisition, J.C. and L.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work is supported by the National Natural Science Foundation of China (22108017), the Natural Science Foundation of Sichuan Province (2022NSFSC1614), and the Open Funding Project of Meat Processing Key Laboratory of Sichuan Province (23-R-06, 23-R-07). This work is also partially supported by the Open Funding Project of the State Key Laboratory of Bioreactor Engineering.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and supplementary materials.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wang, S.; Chen, X.; Jin, X.; Gu, F.; Jiang, W.; Qi, Q.; Liang, Q. Creating Polyploid Escherichia Coli and Its Application in Efficient L-Threonine Production. Adv. Sci. 2023, 10, e2302417. [Google Scholar] [CrossRef] [PubMed]
  2. Darvishi, F.; Rafatiyan, S.; Abbaspour Motlagh Moghaddam, M.H.; Atkinson, E.; Ledesma-Amaro, R. Applications of synthetic yeast consortia for the production of native and non-native chemicals. Crit. Rev. Biotechnol. 2022, 44, 15–30. [Google Scholar] [CrossRef] [PubMed]
  3. Cheng, J.; Huang, Y.; Mi, L.; Chen, W.; Wang, D.; Wang, Q. An economically and environmentally acceptable synthesis of chiral drug intermediate L-pipecolic acid from biomass-derived lysine via artificially engineered microbes. J. Ind. Microbiol. Biotechnol. 2018, 45, 405–415. [Google Scholar] [CrossRef] [PubMed]
  4. Wang, L.; Wang, H.; Chen, J.; Qin, Z.; Yu, S.; Zhou, J. Coordinating caffeic acid and salvianic acid A pathways for efficient production of rosmarinic acid in Escherichia coli. Metab. Eng. 2023, 76, 29–38. [Google Scholar] [CrossRef] [PubMed]
  5. Qin, Z.; Wang, X.; Gao, S.; Li, D.; Zhou, J. Production of Natural Pigments Using Microorganisms. J. Agric. Food Chem. 2023, 71, 9243–9254. [Google Scholar] [CrossRef] [PubMed]
  6. Wang, L.; Li, N.; Yu, S.; Zhou, J. Enhancing caffeic acid production in Escherichia coli by engineering the biosynthesis pathway and transporter. Bioresour. Technol. 2023, 368, 128320. [Google Scholar] [CrossRef]
  7. Jungmann, L.; Hoffmann, S.L.; Lang, C.; De Agazio, R.; Becker, J.; Kohlstedt, M.; Wittmann, C. High-efficiency production of 5-hydroxyectoine using metabolically engineered Corynebacterium glutamicum. Microb. Cell Factories 2022, 21, 274. [Google Scholar] [CrossRef]
  8. Yu, S.; Shan, X.; Lyv, Y.; Zhou, J. Bioproduction of quercetin using recombinant thermostable glycosidases from Dictyoglomus thermophilum. Bioresour. Bioprocess. 2022, 9, 48. [Google Scholar] [CrossRef]
  9. Li, D.; Wang, X.; Qin, Z.; Yu, S.; Chen, J.; Zhou, J. Combined engineering of l-sorbose dehydrogenase and fermentation optimization to increase 2-keto-l-gulonic acid production in Escherichia coli. Bioresour. Technol. 2023, 372, 128672. [Google Scholar] [CrossRef]
  10. Qiu, Y.; Chen, Z.; Su, E.; Wang, L.; Sun, L.; Lei, P.; Xu, H.; Li, S. Recent Strategies for the Biosynthesis of Ergothioneine. J. Agric. Food Chem. 2021, 69, 13682–13690. [Google Scholar] [CrossRef]
  11. Luckie, B.A.; Kashyap, M.; Pearson, A.N.; Chen, Y.; Liu, Y.; Valencia, L.E.; Romero, A.C.; Hudson, G.A.; Tao, X.B.; Wu, B.; et al. Development of Corynebacterium glutamicum as a monoterpene production platform. Metab. Eng. 2023, 81, 110–122. [Google Scholar] [CrossRef] [PubMed]
  12. Xu, S.; Zhang, B.; Chen, W.; Ye, K.; Shen, J.; Liu, P.; Wu, J.; Wang, H.; Chu, X. Highly efficient production of ectoine via an optimized combination of precursor metabolic modules in Escherichia coli BL21. Bioresour. Technol. 2023, 390, 129803. [Google Scholar] [CrossRef] [PubMed]
  13. Zhang, M.; Gao, C.; Guo, X.; Guo, S.; Kang, Z.; Xiao, D.; Yan, J.; Tao, F.; Zhang, W.; Dong, W.; et al. Increased glutarate production by blocking the glutaryl-CoA dehydrogenation pathway and a catabolic pathway involving L-2-hydroxyglutarate. Nat. Commun. 2018, 9, 2114. [Google Scholar] [CrossRef] [PubMed]
  14. Darvishi, F.; Blenner, M.; Ledesma-Amaro, R. Editorial: Synthetic Biology of Yeasts for the Production of Non-Native Chemicals. Front. Bioeng. Biotechnol. 2021, 9, 730047. [Google Scholar] [CrossRef]
  15. Wu, L.; An, J.; Jing, X.; Chen, C.-C.; Dai, L.; Xu, Y.; Liu, W.; Guo, R.-T.; Nie, Y. Molecular Insights into the Regioselectivity of the Fe(II)/2-Ketoglutarate-Dependent Dioxygenase-Catalyzed C–H Hydroxylation of Amino Acids. ACS Catal. 2022, 12, 11586–11596. [Google Scholar] [CrossRef]
  16. Zhang, Z.; Liu, P.; Su, W.; Zhang, H.; Xu, W.; Chu, X. Metabolic engineering strategy for synthetizing trans-4-hydroxy-L-proline in microorganisms. Microb. Cell Factories 2021, 20, 87. [Google Scholar] [CrossRef] [PubMed]
  17. Vargas, M.A.; Deive, F.J.; Alvarez, M.S.; Longo, M.A.; Rodriguez, A.; Bernal, C.; Martinez, R. Effect of process parameters and surfactant additives on the obtained activity of recombinant tryptophan hydroxylase (TPH1) for enzymatic synthesis of 5-hydroxytryptophan (5-HTP). Enzym. Microb. Technol. 2022, 154, 109975. [Google Scholar] [CrossRef]
  18. Luo, Z.; Wang, Z.; Wang, B.; Lu, Y.; Yan, L.; Zhao, Z.; Bai, T.; Zhang, J.; Li, H.; Wang, W.; et al. An Artificial Pathway for N-Hydroxy-Pipecolic Acid Production From L-Lysine in Escherichia coli. Front. Microbiol. 2022, 13, 842804. [Google Scholar] [CrossRef]
  19. Kawahara, T.; Itoh, M.; Kozone, I.; Izumikawa, M.; Sakata, N.; Tsuchida, T.; Shin-Ya, K. MBJ-0110, a novel cyclopeptide isolated from the fungus Penicillium sp. f25267. J. Antibiot. 2016, 69, 66–68. [Google Scholar] [CrossRef]
  20. Wang, B.X.; Xiao, S.J.; Zhao, X.T.; Zhao, L.M.; Zhang, Y.; Cheng, J.; Zhang, J.M. Recent Advances in the Hydroxylation of Amino Acids and Its Derivatives. Fermentation 2023, 9, 285. [Google Scholar] [CrossRef]
  21. Baud, D.; Peruch, O.; Saaidi, P.-L.; Fossey, A.; Mariage, A.; Petit, J.-L.; Salanoubat, M.; Vergne-Vaxelaire, C.; de Berardinis, V.; Zaparucha, A. Biocatalytic Approaches towards the Synthesis of Chiral Amino Alcohols from Lysine: Cascade Reactions Combining alpha-Keto Acid Oxygenase Hydroxylation with Pyridoxal Phosphate- Dependent Decarboxylation. Adv. Synth. Catal. 2017, 359, 1563–1569. [Google Scholar] [CrossRef]
  22. Wang, F.; Zhu, M.; Song, Z.; Li, C.; Wang, Y.; Zhu, Z.; Sun, D.; Lu, F.; Qin, H.-M. Reshaping the Binding Pocket of Lysine Hydroxylase for Enhanced Activity. ACS Catal. 2020, 10, 13946–13956. [Google Scholar] [CrossRef]
  23. Zhang, X.; King-Smith, E.; Renata, H. Total Synthesis of Tambromycin by Combining Chemocatalytic and Biocatalytic C-H Functionalization. Angew. Chem. 2018, 57, 5037–5041. [Google Scholar] [CrossRef] [PubMed]
  24. Amatuni, A.; Renata, H. Identification of a lysine 4-hydroxylase from the glidobactin biosynthesis and evaluation of its biocatalytic potential. Org. Biomol. Chem. 2019, 17, 1736–1739. [Google Scholar] [CrossRef]
  25. Seide, S.; Arnold, L.; Wetzels, S.; Bregu, M.; Gätgens, J.; Pohl, M. From Enzyme to Preparative Cascade Reactions with Immobilized Enzymes: Tuning Fe(II)/α-Ketoglutarate-Dependent Lysine Hydroxylases for Application in Biotransformations. Catalysts 2022, 12, 354. [Google Scholar] [CrossRef]
  26. Froidevaux, V.; Negrell, C.; Caillol, S.; Pascault, J.P.; Boutevin, B. Biobased Amines: From Synthesis to Polymers; Present and Future. Chem. Rev. 2016, 116, 14181–14224. [Google Scholar] [CrossRef] [PubMed]
  27. Li, Y.; Zhang, A.; Hu, S.; Chen, K.; Ouyang, P. Efficient and scalable synthesis of 1,5-diamino-2-hydroxy-pentane from L-lysine via cascade catalysis using engineered Escherichia coli. Microb. Cell Factories 2022, 21, 142. [Google Scholar] [CrossRef]
  28. Zhang, J.D.; Zhao, J.W.; Gao, L.L.; Chang, H.H.; Wei, W.L.; Xu, J.H. Enantioselective synthesis of enantiopure beta-amino alcohols via kinetic resolution and asymmetric reductive amination by a robust transaminase from Mycobacterium vanbaalenii. J. Biotechnol. 2019, 290, 24–32. [Google Scholar] [CrossRef]
  29. Fossey-Jouenne, A.; Vergne-Vaxelaire, C.; Zaparucha, A. Enzymatic Cascade Reactions for the Synthesis of Chiral Amino Alcohols from L-lysine. J. Vis. Exp. JoVE 2018, 132, e56926. [Google Scholar] [CrossRef]
  30. Steinreiber, J.; Schürmann, M.; van Assema, F.; Wolberg, M.; Fesko, K.; Reisinger, C.; Mink, D.; Griengl, H. Synthesis of Aromatic 1,2-Amino Alcohols Utilizing a Bienzymatic Dynamic Kinetic Asymmetric Transformation. Adv. Synth. Catal. 2007, 349, 1379–1386. [Google Scholar] [CrossRef]
  31. Souers, A.J.; Leverson, J.D.; Boghaert, E.R.; Ackler, S.L.; Catron, N.D.; Chen, J.; Dayton, B.D.; Ding, H.; Enschede, S.H.; Fairbrother, W.J.; et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 2013, 19, 202–208. [Google Scholar] [CrossRef] [PubMed]
  32. Wang, J.; Bettinger, C.J.; Langer, R.S.; Borenstein, J.T. Biodegradable microfluidic scaffolds for tissue engineering from amino alcohol-based poly(ester amide) elastomers. Organogenesis 2010, 6, 212–216. [Google Scholar] [CrossRef] [PubMed]
  33. Tufvesson, P.; Lima-Ramos, J.; Nordblad, M.; Woodley, J.M. Guidelines and Cost Analysis for Catalyst Production in Biocatalytic Processes. Org. Process Res. Dev. 2011, 15, 266–274. [Google Scholar] [CrossRef]
  34. Hryc, C.F.; Baker, M.L. AlphaFold2 and CryoEM: Revisiting CryoEM modeling in near-atomic resolution density maps. iScience 2022, 25, 104496. [Google Scholar] [CrossRef]
  35. Zeng, W.; Wang, P.; Li, N.; Li, J.; Chen, J.; Zhou, J. Production of 2-keto-L-gulonic acid by metabolically engineered Escherichia coli. Bioresour. Technol. 2020, 318, 124069. [Google Scholar] [CrossRef] [PubMed]
  36. Fan, L.; Wang, Y.; Tuyishime, P.; Gao, N.; Li, Q.; Zheng, P.; Sun, J.; Ma, Y. Engineering Artificial Fusion Proteins for Enhanced Methanol Bioconversion. ChemBioChem 2018, 19, 2465–2471. [Google Scholar] [CrossRef]
  37. Annamalai, N.; Veeramuthu Rajeswari, M.; Vijayalakshmi, S.; Balasubramanian, T. Purification and characterization of chitinase from Alcaligenes faecalis AU02 by utilizing marine wastes and its antioxidant activity. Ann. Microbiol. 2011, 61, 801–807. [Google Scholar] [CrossRef]
  38. Zhang, K.; Sawaya, M.R.; Eisenberg, D.S.; Liao, J.C. Expanding metabolism for biosynthesis of nonnatural alcohols. Proc. Natl. Acad. Sci. USA 2008, 105, 20653–20658. [Google Scholar] [CrossRef]
  39. Tan, H.; Zhou, H.; Guo, T.; Zhang, Y.; Ma, L. Integrated multi-spectroscopic and molecular modeling techniques to study the formation mechanism of hidden zearalenone in maize. Food Chem. 2021, 351, 129286. [Google Scholar] [CrossRef]
  40. Prell, C.; Vonderbank, S.-A.; Meyer, F.; Pérez-García, F.; Wendisch, V.F. Metabolic engineering of Corynebacterium glutamicum for de novo production of 3-hydroxycadaverine. Curr. Res. Biotechnol. 2022, 4, 32–46. [Google Scholar] [CrossRef]
  41. Liu, K.; Yu, H.; Sun, G.; Liu, Y.; Li, J.; Du, G.; Lv, X.; Liu, L. Semi-rational design of L-amino acid deaminase for production of pyruvate and D-alanine by Escherichia coli whole-cell biocatalyst. Amino Acids 2021, 53, 1361–1371. [Google Scholar] [CrossRef] [PubMed]
  42. Pang, C.; Yin, X.; Zhang, G.; Liu, S.; Zhou, J.; Li, J.; Du, G. Current progress and prospects of enzyme technologies in future foods. Syst. Microbiol. Biomanuf. 2020, 1, 24–32. [Google Scholar] [CrossRef]
Fermentation 10 00056 g001
Figure 1. (A) The heterogeneous pathway for 2HyC production from lysine in E. coli. 2HyC, 2-hydroxycadaverine. (B) Bifunctional compounds and chiral amino alcohols are widely applied in many important fields. Red “×” represents gene deletion.
Figure 1. (A) The heterogeneous pathway for 2HyC production from lysine in E. coli. 2HyC, 2-hydroxycadaverine. (B) Bifunctional compounds and chiral amino alcohols are widely applied in many important fields. Red “×” represents gene deletion.
Fermentation 10 00056 g001
Fermentation 10 00056 g002
Figure 2. Structural modeling of KDOKr and molecular docking. (A) Overall architecture of KDOKr; (B) Interactions of the ligand L-lysine with their surroundings in the KDOKr system; the cartoon model represents the KDOKr structure; (C) 3D interaction diagram of L-lysine with KDOKr protein. (D) Schematic diagram of the interactions of KDOKr with L-lysine (a green dotted line indicates hydrogen bond and a red dotted line indicates a hydrophobic interaction). KDOKr, lysine hydroxylase, from Kineococcus radiotolerans.
Figure 2. Structural modeling of KDOKr and molecular docking. (A) Overall architecture of KDOKr; (B) Interactions of the ligand L-lysine with their surroundings in the KDOKr system; the cartoon model represents the KDOKr structure; (C) 3D interaction diagram of L-lysine with KDOKr protein. (D) Schematic diagram of the interactions of KDOKr with L-lysine (a green dotted line indicates hydrogen bond and a red dotted line indicates a hydrophobic interaction). KDOKr, lysine hydroxylase, from Kineococcus radiotolerans.
Fermentation 10 00056 g002
Fermentation 10 00056 g003
Figure 3. The binding pattern diagram of 3-hydroxylysine with the DCCp protein. (A) The distribution of 3-hydroxylysine on the DCCp protein surface; (B) The spatial position of 3-hydroxylysine in the DCCp protein; (C) the 2D interaction diagram of 3-hydroxylysine with the DCCp protein. The green dashed line is for hydrogen bonding, and the red dotted line indicates hydrogen bond; (D) 3D interaction diagram of 3-hydroxylysine with the DCCp protein. DCCp, pyridoxal phosphate-dependent decarboxylase from Chitinophaga pinensis. The red circle represents oxygen atoms, the blue circle represents nitrogen atoms, and the black circle represents carbon atoms.
Figure 3. The binding pattern diagram of 3-hydroxylysine with the DCCp protein. (A) The distribution of 3-hydroxylysine on the DCCp protein surface; (B) The spatial position of 3-hydroxylysine in the DCCp protein; (C) the 2D interaction diagram of 3-hydroxylysine with the DCCp protein. The green dashed line is for hydrogen bonding, and the red dotted line indicates hydrogen bond; (D) 3D interaction diagram of 3-hydroxylysine with the DCCp protein. DCCp, pyridoxal phosphate-dependent decarboxylase from Chitinophaga pinensis. The red circle represents oxygen atoms, the blue circle represents nitrogen atoms, and the black circle represents carbon atoms.
Fermentation 10 00056 g003
Fermentation 10 00056 g004
Figure 4. An artificial pathway confirmed for the biosynthesis of 2HyC via E. coli ML101 and ML102 in 250 mL flasks. A total of 4.0 g/L of L-Lysine was used as a substrate. Values and error bars represent the mean and the standard deviation of triplicate.
Figure 4. An artificial pathway confirmed for the biosynthesis of 2HyC via E. coli ML101 and ML102 in 250 mL flasks. A total of 4.0 g/L of L-Lysine was used as a substrate. Values and error bars represent the mean and the standard deviation of triplicate.
Fermentation 10 00056 g004
Table 1. The strains and plasmids used in this study.
Table 1. The strains and plasmids used in this study.
Strains or PlasmidsRelevant Genotype or DescriptionSource
Strains
BL21(DE3)Wild type[35]
ML03BL21(DE3) ΔcadA[3]
ML10ML03 harboring pET22b-KDOKrThis study
ML101ML03 harboring pET22b-KDOKr-DCCpThis study
ML102ML03 harboring pET22b-KDOKr-DCCp (R53D/V94I)This study
ML11ML03 harboring pET22b-DCCpThis study
Plasmids
pET22b-KDOKrpET22b carries a lysine hydroxylase gene from Kineococcus radiotolerans (KDOKr), AmpRThis study
pET22b-DCCppET22b carries a pyridoxal phosphate-dependent decarboxylase gene from Chitinophage pinensis (DCCp), AmpRThis study
pET22b-KDOKr-DCCppET22b carries a lysine hydroxylase gene from Kineococcus radiotolerans (KDOKr), and a pyridoxal phosphate-dependent decarboxylase gene from Chitinophage pinensis (DCCp), AmpRThis study
pET22b-KDOKr-DCCp (R53D/V94I)pET22b carries a lysine hydroxylase from Kineococcus radiotolerans (KDOKr), and a pyridoxal phosphate-dependent decarboxylase (DCCp) mutant (R53D/V94I) from Chitinophage pinensis (DCCp), AmpR This study
Table 2. Production of 3-hydroxylysine and 2HyC from lysine via recombinant E. coli ML10 and ML101.
Table 2. Production of 3-hydroxylysine and 2HyC from lysine via recombinant E. coli ML10 and ML101.
StrainsTime (h)2 g/L Lysine4 g/L Lysine
3-Hydroxylysine Production (g/L)2HyC Production (mg/L)3-Hydroxylysine Production (g/L)2HyC Production (mg/L)
ML10120.64 ± 0.05-1.15 ± 0.11-
ML101120.47 ± 0.05106.18 ± 5.480.89 ± 0.08195.37 ± 8.95
Table 3. Kinetic parameters of DCCp and its mutant on 3-hydroxylysine.
Table 3. Kinetic parameters of DCCp and its mutant on 3-hydroxylysine.
EnzymesKm (mM)Kcat (s−1)Kcat/Km (mM−1s−1)
DCCp20.72 ± 1.241.86 ± 0.120.0898 ± 0.0035
DCCp (R53D)18.05 ± 1.022.08 ± 0.150.1152 ± 0.0058
DCCp (R53E)19.21 ± 0.892.13 ± 0.180.1109 ± 0.0043
DCCp (V94A)18.48 ± 1.072.24 ± 0.160.1212 ± 0.0066
DCCp (V94I)17.96 ± 1.352.19 ± 0.130.1097 ± 0.0074
DCCp (R53E/V94I)17.12 ± 1.092.25 ± 0.190.1314 ± 0.0063
DCCp (R53D/V94I)16.33 ± 1.182.39 ± 0.170.1466 ± 0.0067
Data are presented as the means ± STDV calculated from at least three replicates. The determination of DCCp activity was conducted on a 1.5 mL reaction mix containing 50 mM of the HEPES buffer (pH 7.5), 1 mM of PLP, 1 mM of DTT and 10 mM of 3-hydroxylysine. The reaction was started by the addition of 1 mg/mL of the protein. The reaction was conducted at 30 °C and stopped by adding 10 μL of 10 M HCl.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cheng, J.; Xiao, S.; Luo, Q.; Wang, B.; Zeng, R.; Zhao, L.; Zhang, J. Engineering an Artificial Pathway to Improve the Bioconversion of Lysine into Chiral Amino Alcohol 2-Hydroxycadaverine Using a Semi-Rational Design. Fermentation 2024, 10, 56. https://doi.org/10.3390/fermentation10010056

AMA Style

Cheng J, Xiao S, Luo Q, Wang B, Zeng R, Zhao L, Zhang J. Engineering an Artificial Pathway to Improve the Bioconversion of Lysine into Chiral Amino Alcohol 2-Hydroxycadaverine Using a Semi-Rational Design. Fermentation. 2024; 10(1):56. https://doi.org/10.3390/fermentation10010056

Chicago/Turabian Style

Cheng, Jie, Shujian Xiao, Qing Luo, Bangxu Wang, Rumei Zeng, Liming Zhao, and Jiamin Zhang. 2024. "Engineering an Artificial Pathway to Improve the Bioconversion of Lysine into Chiral Amino Alcohol 2-Hydroxycadaverine Using a Semi-Rational Design" Fermentation 10, no. 1: 56. https://doi.org/10.3390/fermentation10010056

APA Style

Cheng, J., Xiao, S., Luo, Q., Wang, B., Zeng, R., Zhao, L., & Zhang, J. (2024). Engineering an Artificial Pathway to Improve the Bioconversion of Lysine into Chiral Amino Alcohol 2-Hydroxycadaverine Using a Semi-Rational Design. Fermentation, 10(1), 56. https://doi.org/10.3390/fermentation10010056

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop